Offer - Urjas Oil for just ₹ 1
Nebycare 2.5 Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of High BP.
The correct dosage of Nebycare 2.5 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Nebycare 2.5 Tablet side effects, there are can be others also. These have been listed below. These side effects of Nebycare 2.5 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Nebycare 2.5 Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Nebycare 2.5 Tablet's effects on the liver, heart and kidney are discussed below in the Nebycare 2.5 Tablet related warnings section.
Nebycare 2.5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Nebycare 2.5 Tablet in conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease). The section on Nebycare 2.5 Tablet contraindications lists all such conditions.
Besides this, Nebycare 2.5 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Nebycare 2.5 Tablet is not safe while driving, and is is not addictive in nature.
Nebycare 2.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Nebycare 2.5 Tablet safe for pregnant women?
Nebycare has many dangerous side effects in pregnant women. If you are pregnant, do not consume Nebycare without medical advice.
Is the use of Nebycare 2.5 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Nebycare. So it is adviced to consult the doctor before using it.
What is the effect of Nebycare 2.5 Tablet on the Kidneys?
Nebycare rarely affects the kidneys.
What is the effect of Nebycare 2.5 Tablet on the Liver?
Nebycare may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Nebycare 2.5 Tablet on the Heart?
Nebycare may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Nebycare 2.5 Tablet unless your doctor advises you to do so -
Is this Nebycare 2.5 Tablet habit forming or addictive?
No, you will not get addicted to Nebycare 2.5 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nebycare 2.5 Tablet, you should not drive or work on any heavy machine, as Nebycare 2.5 Tablet can make you drowsy.
Is it safe?
Nebycare 2.5 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Nebycare 2.5 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Nebycare 2.5 Tablet
Taking Nebycare 2.5 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Nebycare 2.5 Tablet
Consult your doctor before consuming alcohol while taking Nebycare 2.5 Tablet as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897
